File Download

There are no files associated with this item.

  • Find it @ UNIST can give you direct access to the published full text of this article. (UNISTARs only)
Related Researcher

채영찬

Chae, Young Chan
Cancer Translational Research Lab.
Read More

Views & Downloads

Detailed Information

Cited time in webofscience Cited time in scopus
Metadata Downloads

Mitochondrial Akt Regulation of Hypoxic Tumor Reprogramming

Author(s)
Chae, Young ChanVaira, ValentinaCaino, M. CeciliaTang, Hsin-YaoSeo, Jae HoKossenkov, Andrew V.Ottobrini, LuisaMartelli, CristinaLucignani, GiovanniBertolini, IreneLocatelli, MarcoBryant, Kelly G.Ghosh, Jagadish C.Lisanti, SofiaKu, BonsuBosari, SilvanoLanguino, Lucia R.Speicher, David W.Altieri, Dario C.
Issued Date
2016-08
DOI
10.1016/j.ccell.2016.07.004
URI
https://scholarworks.unist.ac.kr/handle/201301/21827
Fulltext
http://www.sciencedirect.com/science/article/pii/S153561081630335X
Citation
CANCER CELL, v.30, no.2, pp.257 - 272
Abstract
Hypoxia is a universal driver of aggressive tumor behavior, but the underlying mechanisms are not completely understood. Using a phosphoproteomics screen, we now show that active Akt accumulates in the mitochondria during hypoxia and phosphorylates pyruvate dehydrogenase kinase 1 (PDK1) on Thr346 to inactivate the pyruvate dehydrogenase complex. In turn, this pathway switches tumormetabolism toward glycolysis, antagonizes apoptosis and autophagy, dampens oxidative stress, and maintains tumor cell proliferation in the face of severe hypoxia. Mitochondrial Akt-PDK1 signaling correlates with unfavorable prognostic markers and shorter survival in glioma patients and may provide an "actionable'' therapeutic target in cancer.
Publisher
CELL PRESS
ISSN
1535-6108

qrcode

Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.